JP2020525416A5 - - Google Patents

Download PDF

Info

Publication number
JP2020525416A5
JP2020525416A5 JP2019569289A JP2019569289A JP2020525416A5 JP 2020525416 A5 JP2020525416 A5 JP 2020525416A5 JP 2019569289 A JP2019569289 A JP 2019569289A JP 2019569289 A JP2019569289 A JP 2019569289A JP 2020525416 A5 JP2020525416 A5 JP 2020525416A5
Authority
JP
Japan
Prior art keywords
heparin
ophthalmic
eye
disease
coagulable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019569289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020525416A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/020455 external-priority patent/WO2019005222A1/en
Publication of JP2020525416A publication Critical patent/JP2020525416A/ja
Publication of JP2020525416A5 publication Critical patent/JP2020525416A5/ja
Pending legal-status Critical Current

Links

JP2019569289A 2017-06-29 2018-03-01 眼表面障害の治療及び診断 Pending JP2020525416A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762526891P 2017-06-29 2017-06-29
US62/526,891 2017-06-29
US201762575508P 2017-10-22 2017-10-22
US62/575,508 2017-10-22
PCT/US2018/020455 WO2019005222A1 (en) 2017-06-29 2018-03-01 TREATMENT AND DIAGNOSIS OF OCULAR SURFACE DISORDERS

Publications (2)

Publication Number Publication Date
JP2020525416A JP2020525416A (ja) 2020-08-27
JP2020525416A5 true JP2020525416A5 (cg-RX-API-DMAC7.html) 2021-05-20

Family

ID=64734716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019569289A Pending JP2020525416A (ja) 2017-06-29 2018-03-01 眼表面障害の治療及び診断

Country Status (4)

Country Link
US (2) US11058713B2 (cg-RX-API-DMAC7.html)
EP (1) EP3644966A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020525416A (cg-RX-API-DMAC7.html)
WO (1) WO2019005222A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230091716A1 (en) * 2020-02-12 2023-03-23 Glia, Llc Progesterone Combinations
DE102020104540A1 (de) * 2020-02-20 2021-08-26 Carl Zeiss Meditec Ag Ophthalmologische Zusammensetzung und Detektionsvorrichtung für ein medizinisches Gerät
US20220160668A1 (en) 2020-11-23 2022-05-26 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye
KR102391198B1 (ko) * 2021-08-27 2022-04-27 한림제약(주) 리피테그라스트 또는 이의 약제학적으로 허용가능한 염을 포함하는 수용액 형태의 점안액 조성물
JP7514033B2 (ja) * 2022-08-23 2024-07-10 株式会社エムズサイエンス 角膜障害治療剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2207049A (en) * 1987-07-15 1989-01-25 Steven B Siepser Heparin formulation for use in eye surgery
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
BR0013793A (pt) * 1999-09-06 2002-05-14 Ono Pharmaceutical Co Medicamentos profiláticos e terapêuticos para doenças oftálmicas
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
CN1394610A (zh) * 2002-07-12 2003-02-05 黄建林 肝素钙眼药水
CN1459291A (zh) * 2003-05-28 2003-12-03 凌沛学 含低分子肝素的滴眼液及其制备方法
EP1720555A1 (en) * 2004-02-26 2006-11-15 Advanced Ocular Systems Limited Tetracycline derivatives for the treatment of ocular pathologies
GB0404693D0 (en) * 2004-03-02 2004-04-07 Univ London Pharmaceutical preparations for the treatment of ocular surface and other disorders
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20060122152A1 (en) * 2004-12-03 2006-06-08 Peyman Gholam A Heparin for the treatment of ocular pathologies
US20060276440A1 (en) * 2005-01-03 2006-12-07 An Wenqian F Treatment of inflammatory disorders
WO2006086638A2 (en) * 2005-02-10 2006-08-17 Board Of Regents, The University Of Texas System Targeting lipocalin-2 for cancer therapeutics
US20100189721A1 (en) * 2007-07-06 2010-07-29 Smithkline Beecham Corporation Antibody formulations
US20090253661A1 (en) * 2008-04-04 2009-10-08 Gholam A. Peyman Ocular agents
CA2858983C (en) * 2011-12-12 2020-06-09 The Board Of Trustees Of The University Of Illinois Composition and method for treating nucleic acid-related eye disease
TR201902752T4 (tr) * 2011-12-23 2019-03-21 Univ Of Western Sydney Oftalmik formülasyon.
RU2535115C1 (ru) * 2013-05-15 2014-12-10 Бости Трейдинг Лтд Фармацевтический состав, содержащий нейротоксин ботулина
JP2017504327A (ja) * 2014-01-14 2017-02-09 カイマブ・リミテッド 抗light抗体
AU2016274868B2 (en) * 2015-06-11 2021-02-18 Attwill Medical Solutions Inc. Medical devices, systems, and methods utilizing antithrombin-heparin compositions
JP7083757B2 (ja) * 2016-02-29 2022-06-13 サンテン エスエーエス ドライアイ疾患の予後のための遺伝子シグネチャー

Similar Documents

Publication Publication Date Title
AU2011284589B2 (en) Compounds for the treatment/prevention of ocular inflammatory diseases
AU2019232153B2 (en) Ophthalmic formulation
JP7547411B2 (ja) 局所用シクロスポリン含有製剤およびその使用
JP6096731B2 (ja) ドライアイ症候群の治療のための医薬組成物
US20210205217A1 (en) Microemulsion compositions
JP2024116245A5 (cg-RX-API-DMAC7.html)
US20120004158A1 (en) Quaternised Ammonium Cyclodextrin Compounds
KR101778004B1 (ko) 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물
JP2017507158A5 (cg-RX-API-DMAC7.html)
RU2632107C2 (ru) Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник
Brjesky et al. Glaucoma and the dry eye syndrome
CN103209683A (zh) 角鲨胺的眼用制剂
CN1302812C (zh) 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法
JP6931493B2 (ja) 緑内障治療用点眼組成物
JP2026004313A (ja) 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの結晶形態及びその製剤
WO2025261323A1 (zh) 一种依维莫司眼局部给药制剂
CN100522147C (zh) 5,6,7-三羟基庚酸及其类似物在制备治疗干眼病和眼色素层炎药物中的应用
EP3539533B1 (en) Eye-drop composition for lowering intraocular pressure
DK3229780T3 (en) Ophthalmic composition for use in the treatment of dry eye syndrome
US20180221417A1 (en) Treatment of dry eye using amnion released factors
KR102790252B1 (ko) 각막 손상 또는 안구건조증 예방 또는 치료용 조성물
JP2017007995A (ja) 洗眼剤組成物及び洗眼方法
JPWO2006098292A1 (ja) 眼疾患治療剤
CN116474105A (zh) 一种预防、缓解或治疗眼部疾病的药物组合物、制备方法及其应用
WO2024024920A1 (ja) 眼科用組成物